{
  "id": 1275,
  "text": "However, the few series reported in literature mainly consist of small retrospective series with heterogeneous cohorts consisting of mixed stages, histology and treatment, with inherent bias.The risk of potential disease in the parametria and LNs become relevant from tumour stage pT1a2 LVSI $^ +$ and beyond.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: However, the few series reported in literature mainly consist of small retrospective series with heterogeneous cohorts consisting of mixed stages, histology and treatment, with inherent bias.The risk of potential disease in the parametria and LNs become relevant from tumour stage pT1a2 LVSI $^ +$ and beyond.\n\n<question>: ",
  "ChatGPT_response_0": "在处理肿瘤分期为 pT1a2 LVSI $^ +$ 的患者时，临床医生需要根据患者的具体情况来制定个性化的治疗方案。首先，需要全面评估患者的病情，包括病理分析、临床表现、病史等信息。其次，应结合最新的指南和临床实践经验，考虑手术治疗、放疗、化疗等综合治疗方案。对于存在潜在疾病风险的患者，需要更加密切地监测病情变化，进行定期复查和随访。此外，医生还需要与患者充分沟通，解释治疗的可能风险和益处，帮助患者做出明智的决策。综合而言，个性化治疗和定期监测是在临床实践中处理这种情况的关键措施。",
  "query": "在文献中报告的那些系列主要由小型回顾性系列组成，队伍混杂，包括不同阶段、组织学和治疗，因此存在固有偏见。从肿瘤分期为 pT1a2 LVSI $^ +$ 开始，盆腔和淋巴结可能存在潜在疾病风险。你认为这种情况下如何在临床实践中进行处理？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在文献中报告的那些系列主要由小型回顾性系列组成，队伍混杂，包括不同阶段、组织学和治疗，因此存在固有偏见。从肿瘤分期为 pT1a2 LVSI $^ +$ 开始，盆腔和淋巴结可能存在潜在疾病风险。你认为这种情况下如何在临床实践中进行处理？\n\n<reference text>: However, the few series reported in literature mainly consist of small retrospective series with heterogeneous cohorts consisting of mixed stages, histology and treatment, with inherent bias.The risk of potential disease in the parametria and LNs become relevant from tumour stage pT1a2 LVSI $^ +$ and beyond.\n\n<reply>: ",
  "response": "在处理肿瘤分期为 pT1a2 LVSI $^ +$ 的患者时，临床医生需要根据患者的具体情况来制定个性化的治疗方案。首先，需要全面评估患者的病情，包括病理分析、临床表现、病史等信息。其次，应结合最新的指南和临床实践经验，考虑手术治疗、放疗、化疗等综合治疗方案。对于存在潜在疾病风险的患者，需要更加密切地监测病情变化，进行定期复查和随访。此外，医生还需要与患者充分沟通，解释治疗的可能风险和益处，帮助患者做出明智的决策。综合而言，个性化治疗和定期监测是在临床实践中处理这种情况的关键措施。"
}